Security key
M47238106
- Security type / class
- Equity / SHS
- Total 13F shares
- 5,887,801
- Total 13F value
- $34,031,780
- Share change
- -565,398
- SEC-reported price per share
- $5.78
- Number of holders
- 31
- Value change
- -$2,917,036
- Number of buys
- 14
- Number of sells
- 12
Report period
Q4 2019
Institutions
31
Top holders
10
GLMD full security history
Ownership snapshot
Full 13F holder table
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Sep 2019
13F
Highest disclosed value: $8,759,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL has the largest disclosed position value at $8.76M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Disclosed position value
Top 5
BVF INC/IL
$8.76M
683 Capital Management, LLC
$6.48M
IBEX INVESTORS LLC
$4.56M
Nantahala Capital Management, LLC
$4.2M
RAYMOND JAMES & ASSOCIATES
$1.22M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$8,759,000
1,832,484 shares
|
— | 30 Sep 2019 |
| 683 Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$6,483,000
1,356,356 shares
|
— | 30 Sep 2019 |
| IBEX INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$4,565,000
955,105 shares
|
— | 30 Sep 2019 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$4,203,000
879,200 shares
|
— | 30 Sep 2019 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
—
denominator unverified
|
$1,215,000
254,265 shares
|
— | 30 Sep 2019 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$1,031,000
215,594 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
5,887,801
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
30
Q4 2019 holders
31
Holder diff
1
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|